20.500.12556/DiRROS-8154 Letno srečanje ASCO ASCO Annual Meeting In the end of May this year, Chicago hosted the traditional annual meeting of oncologists from around the world, which was organised by the American Society of Clinical Oncology (ASCO). Once again, the meeting was attended by more than 30,000 oncologists and other scientists from all over the world. The main topic of this year’s ASCO meeting was definitely cancer immunotherapy. For many years, we have hoped to be able to destroy or at least control cancer cells by stimulating the organism’s own defence. There have been some ups but mostly many downs of immunotherapy. Interferons, interleukins and vaccines have shown a very small level of efficacy, and, even so, only in some types of cancer, alongside a disproportionally high toxicity. A breakthrough was achieved a few years ago, when new immuno-medicines, inhibitors of control switches in T lymphocytes (so-called checkpoint inhibitors), were introduced into clinical trials. In many types of cancer, these medicines led to remissions, which were, most importantly, long-term in patients with remission. klinična onkologija imunoterapija imunska zdravila novosti true false false Slovenski jezik Angleški jezik by Authors Neznano 2018-01-03 12:27:28 2018-03-19 11:32:04 2022-08-16 09:56:52 0000-00-00 00:00:00 2015 0 0 str. 30-32 št. 1 Letn. 19 jun. 2015 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616-006 1408-1741 2139771 65324032 RAZ_Cufer_Tanja_i2015.pdf RAZ_Cufer_Tanja_i2015.pdf 1 DB394AED358E995AD5C6942B5420B414 913738df4526980ada02afcf96be425644ede94fd07144dc1c96bd13c3d2af76 4860ef7f-17b5-11ed-b6b8-001a4af901a5 20.500.12556/dirros/350c04b1-ea3d-4086-8a08-de974893dc0a https://dirros.openscience.si/Dokument.php?lang=slv&id=10110 Onkološki inštitut Ljubljana Onkologija : strokovni časopis za zdravnike 0 0 0